1. Liang, Yichao, Wu, Di, Qu, Qiao, Li, Zhilong, Yin, Hongzhuan. 2023. MORC4 plays a tumor-promoting role in colorectal cancer via regulating PCGF1/CDKN1A axis in vitro and in vivo. In Cancer gene therapy, 30, 985-996. doi:10.1038/s41417-023-00605-2. https://pubmed.ncbi.nlm.nih.gov/36932196/
2. Yang, Zi'ang, Zhuang, Qiulin, Hu, Guangfu, Geng, Shengkai. 2018. MORC4 is a novel breast cancer oncogene regulated by miR-193b-3p. In Journal of cellular biochemistry, 120, 4634-4643. doi:10.1002/jcb.27751. https://pubmed.ncbi.nlm.nih.gov/30320920/
3. Giri, Anil K, Midha, Shallu, Banerjee, Priyanka, Garg, Pramod K, Bharadwaj, Dwaipayan. 2016. Common Variants in CLDN2 and MORC4 Genes Confer Disease Susceptibility in Patients with Chronic Pancreatitis. In PloS one, 11, e0147345. doi:10.1371/journal.pone.0147345. https://pubmed.ncbi.nlm.nih.gov/26820620/
4. Liggins, Amanda P, Cooper, Christopher D O, Lawrie, Charles H, Pulford, Karen, Banham, Alison H. 2007. MORC4, a novel member of the MORC family, is highly expressed in a subset of diffuse large B-cell lymphomas. In British journal of haematology, 138, 479-86. doi:. https://pubmed.ncbi.nlm.nih.gov/17608765/
5. Song, Zhaoguang, Yu, Wenyan, Yin, Xuqing. 2025. Identification of telomere-related gene subtypes and prognostic signatures in osteosarcoma. In Frontiers in pharmacology, 16, 1545913. doi:10.3389/fphar.2025.1545913. https://pubmed.ncbi.nlm.nih.gov/40070565/
智鼠故事 
